Overview
Investor Fact Sheet
News
Pipeline
Pharmaceutical Pipeline
Development Pipeline
Novel Therapies
2023 Key Events
Patent Table
Financials
Quarterly Results
Annual Reports
SEC Filings
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Dividend History
Stock Split Information
Governance
Corporate Governance Overview
2023 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG Resources
2022 Health for Humanity Report
2022 Janssen Transparency Report
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Skip to main content
Investor Relations
About J&J
Our Stories
Our Initiatives
Investors
Careers
jnj.com
Investor FAQs
Overview
Investor Fact Sheet
News
Pipeline
Pharmaceutical Pipeline
Development Pipeline
Novel Therapies
2023 Key Events
Patent Table
Financials
Quarterly Results
Annual Reports
SEC Filings
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Dividend History
Stock Split Information
Governance
Corporate Governance Overview
2023 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG Resources
2022 Health for Humanity Report
2022 Janssen Transparency Report
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Contact Investor Relations
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com